Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Assignees
MemberSunflower TherapeuticsSunflower TherapeuticsSunflower Therapeutics is a women-owned and led biotechnology public benefit corporation founded in 2018, dedicated to democratizing access to protein manufacturing worldwide. The company develops next-generation, automated, and fully-integrated protein manufacturing solutions that simplify the process from discovery to full-scale biomanufacturing. Their mission is to make high-quality, cost-effective therapeutics, vaccines, and protein-based products accessible globally, especially in low- and middle-income countries, by leveraging innovative technologies, sustainable practices, and intuitive equipment. Sunflower’s vision is to transform the global health landscape by enabling more medicines and protein products to reach patients and consumers everywhere. Their core technologies include efficient microbial hosts, data-driven process development, and modular manufacturing facilities, supporting agile, rapid, and cost-effective production cycles for a wide range of protein-based products.
Sunflower Therapeutics is a women-owned and led biotechnology public benefit corporation founded in 2018, dedicated to democratizing access to protein manufacturing worldwide. The company develops next-generation, automated, and fully-integrated protein manufacturing solutions that simplify the process from discovery to full-scale biomanufacturing. Their mission is to make high-quality, cost-effective therapeutics, vaccines, and protein-based products accessible globally, especially in low- and middle-income countries, by leveraging innovative technologies, sustainable practices, and intuitive equipment. Sunflower’s vision is to transform the global health landscape by enabling more medicines and protein products to reach patients and consumers everywhere. Their core technologies include efficient microbial hosts, data-driven process development, and modular manufacturing facilities, supporting agile, rapid, and cost-effective production cycles for a wide range of protein-based products.
Abstract
A structured assembly of perpendicular, interwoven fluidic conduits permits connections between conduits to be readily (and in some cases visibly) established, thereby providing operational convenience and amenability to automated means of validation or verification.
Core Innovation
The invention is a fluid transport and distribution manifold with first and second pluralities of parallel fluid conduits passing through a support. The conduit pluralities are perpendicular to and interwoven with each other, and at least some conduits in the second plurality are selectably fluidly connected to one or more conduits in the first plurality. In one arrangement, the first plurality terminates at a multiport valve head.
The described configurations include permanent connections or adjustable, valved connections, with check valves and electronic valve adjustment also specified. The support may comprise a rigid frame retaining the conduits in their perpendicular, interwoven configuration, and the conduits may be interlaced as warp and weft. The background section is not included in the supplied content, so the problem being solved is not explicitly described in patent.
Claims Coverage
The five independent claims are claims 1, 5, 13, 17, and 18. They cover four manifold configurations and a method of fluid transport, summarized below as five inventive features.
Manifold with a multiport valve head
Claim 1 covers a support carrying perpendicular, interwoven pluralities of parallel fluid conduits, with selectable fluid connections between the pluralities and the first plurality terminating at a multiport valve head.
Manifold with adjustable check valves
Claim 5 covers perpendicular, interwoven pluralities of parallel fluid conduits with selectable fluid connections established by adjustable transfer valves that are check valves.
Manifold retained by a rigid frame
Claim 13 covers perpendicular, interwoven pluralities of parallel fluid conduits with selectable fluid connections, retained in that configuration by a rigid frame of the support.
Manifold with warp-and-weft conduits
Claim 17 covers perpendicular, interwoven pluralities of parallel fluid conduits, with the conduits interlaced as warp and weft and selected conduits fluidly connected.
Method of fluid transport through interwoven conduits
Claim 18 covers interweaving substantially perpendicular pluralities of parallel fluid conduits retained by a rigid frame and/or having the first plurality terminate at a multiport valve head, fluidly connecting at least some conduits, and causing fluid to flow from the first plurality into connected conduits in the second plurality.
The independent claims cover selectable fluid connections between perpendicular, interwoven conduit arrays, with variations specifying a multiport valve head, adjustable check valves, rigid-frame retention, warp-and-weft interlacing, or fluid transport through the arrays.
Stated Advantages
Not explicitly described in patent.
Documented Applications
The manifold is described for bioprocessing, including the distribution of bioprocessing fluids and reagents.
Interested in licensing this patent?